PEOPLE - Matritech makes promotion:
This article was originally published in Clinica
Matritech, a US developer of products for the detection, management and screening of cancer, has promoted Melodie Domurad to vice-president of regulatory and clinical affairs. Dr Domurad joined Matritech in 1997 and has over 10 years of pharmaceutical and device research experience directing clinical programme design and implementation.
You may also be interested in...
To be more transparent and allow more public discourse, the HHS now requires all its agencies to publish documents it uses to rationalize proposed rules and demonstration projects.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.